PIPOC 2007  


December 13, 2019 -Friday


Wednesday 14/08/2019

KUALA LUMPUR, Aug 14 (Bernama) -- Pfizer Upjohn signed a Memorandum of Understanding (MOU) with its seven partners for iMANAGE (Integrated Management of Non-Communicable Diseases for Non-Governmental Organisations), a structured alliance of private healthcare providers to create an integrated healthcare programme. iMANAGE is an initiative to develop and deliver accredited trainings, support systems, and professional networking among general practitioners (GPs), specialists and pharmacists.

The seven partners are Malaysian Association for the Study of Pain (MASP), Academy of Family Physicians Malaysia (AFPM), Malaysian Society of Hypertension (MSH), Malaysian Psychiatric Association (MPA), National Heart Association Malaysia (NHAM), Malaysian Medical Association (MMA) and Malaysian Pharmaceutical Society (MPS).

NCDs are a significant public health concern as the leading cause of death globally[i] and locally[ii]. In Malaysia, NCDs such as cardiovascular disease (CVD), cancer, diabetes, and chronic respiratory disease cause 73% of deaths, with half of them due to CVDs (most common are heart attack and stroke)[iii]. Yet, undiagnosed NCD cases are high and continue to rise each year[iii].

Although NCDs are largely preventable, a major challenge is the alarmingly low health literacy rate of around 7% in Malaysia[iii]. There is a severe lack of education for patients on their health conditions and the importance of medication compliance. Data show that 73% of Malaysians were non-compliant, with 70% requiring further consultation with pharmacists[iv]. There is a critical need for increased patient education and better management of NCDs.

The Ministry of Health (MOH) has highlighted the financial, emotional and human costs resulting from NCDs as a serious concern, and ramped up efforts to address it. To this effect, the government has acknowledged the importance of partnerships between different stakeholders, be it public or private, to drive efforts around curbing the rising rate of NCDs.

“Heeding the call by MOH, Pfizer Upjohn has developed iMANAGE, bringing together seven healthcare partners. The iMANAGE pilot programme will be kicked off in Klang Valley involving 200 GPs and pharmacists, with the objectives of standardising care across the private healthcare providers, promoting knowledge-sharing through a structured support system and improving the health literacy rate,” said Jeff Bote, General Manager, Upjohn Malaysia and Brunei.

The programme will be executed through three key pillars that include:
Education: To bring internationally accredited and locally endorsed trainings and workshops for GPs and pharmacists to ensure standardized care across private healthcare providers.
o Focus area: cardiovascular, mental health and pain management.
Digital networking:  To connect private healthcare providers and create an integrated care ecosystem for the patients.
o Functions: knowledge-sharing, referrals, and validated information.
Mobile application:  To provide customized and validated information to enrolled patients in between the pharmacist and GP visits.
o Make effectiveness of the initiative trackable via real time patient data.

“NCDs disproportionately affect people in low- and middle-income countries where more than three quarters of global NCD deaths occur[v]. As a pledge of our commitment towards providing solutions for NCDs, Upjohn’s vision with iMANAGE is to take an integrated approach among private healthcare providers in Malaysia. Working closely with our partners, we aim to add value to the current healthcare system to create solutions that contribute to improving patients’ lives,” said Dr Chandrashekar Potkar, Chief Medical Officer, Upjohn Emerging Markets.

Upjohn, a new Pfizer division, is primarily focused on relieving the burden of NCDs and delivers healthcare solutions that extend beyond medicines such as high-quality educational resources that help to support health promotion, disease prevention, and healthy aging.

Click here to download the press release translations, partner quotes and photos: https://we.tl/t-koQtESHx0q


[i] Journal of Preventive Medicine & Public Health. Noncommunicable Diseases: Current Status of Major Modifiable Risk Factors in Korea. Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3740221/pdf/jpmph-46-165.pdf. Last accessed 10 July 2019.
[ii] Health Data Org. Malaysia. Retrieved from: http://www.healthdata.org/malaysia. Last accessed 10 July 2019.
[iii] Ministry of Health (MOH) Malaysia. National Health and Morbidity Survey 2015, Non Communicable Diseases & Risk Factors Vol II. Retrieved from: http://www.moh.gov.my/moh/resources/nhmsreport2015vol2.pdf. Last accessed 10 July 2019.
[iv] Pharmaceutical Service Division Ministry of Health. A National Survey on the Use of Medicines by Malaysian Consumers (NSUM) 2015. Retrieved from: https://www.pharmacy.gov.my/v2/sites/default/files/document-upload/national-survey-use-medicine-iii-nsum-iii.pdf. Last accessed 10 July 2019.
[v] World Health Organization (WHO). Non-communicable diseases. Retrieved from: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases. Last accessed 10 July 2019.

Source: Pfizer Upjohn Malaysia

Name: Teoh Seet Heng
Tel: 6017 308 3644 / 603 2775 2724
Email: seet.teoh@hexa-comms.com 

Name: Amy Tan
Pfizer Upjohn
Tel: 6012 388 0312 / 603 2281 6000
Email: Wei-SunAmy.Tan@Pfizer.com




Copyright © 2019 MREM . All rights reserved.